J. D. MACFARLANE, B.M.; M. R. A. KHAIRI, M.D.; M. RICCIARDONE, B.S.; H. N. WELLMAN, M.D.; C. C. JOHNSTON Jr., M.D.
Interest in bone scanning in metabolic bone disease has led to the identification of pseudofractures in osteomalacia (1), the assessment of the severity of renal osteodystrophy (2), and the suggestion that calculation of bone to soft-tissue ratios may help distinguish patients with bone disease from normal control persons (3). These techniques are relatively crude and do not necessarily indicate the real skeletal accretion or whole body retention of the radionuclide. During a study of sequential bone to soft-tissue ratios in patients with various bone diseases, we estimated the renal excretion of 99mTc-ethane-1-hydroxy-1, 1-diphosphonate (99mTc-EHDP). We report here our findings from
Learn more about subscription options.
Register Now for a free account.
MACFARLANE JD, KHAIRI MRA, RICCIARDONE M, WELLMAN HN, JOHNSTON CC. Renal Excretion of 99mTc-Diphosphonate in Osteomalacia. Ann Intern Med. 1979;90:350–351. doi: 10.7326/0003-4819-90-3-350
Download citation file:
Published: Ann Intern Med. 1979;90(3):350-351.
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only